Related Experiment Videos
Gonadal function in young women with Down syndrome
N Angelopoulou1, V Souftas, A Sakadamis
1Department of Physical Education and Sports Science, Aristotle University of Thessaloniki, Greece. angelopo@phed.auth.gr
Summary
Hormonal investigations in women with Down syndrome reveal elevated levels of luteinizing hormone (LH), testosterone (T), and 17-hydroxyprogesterone (17-OHP), suggesting potential gonadal dysfunction. Further research into pituitary-gonadal and pituitary-adrenal axis function is warranted.
Area of Science:
- Endocrinology
- Genetics
- Reproductive Health
Background:
- Down syndrome (trisomy 21) is associated with an increased incidence of gonadal dysfunction.
- Emerging features like Alzheimer disease and osteoporosis highlight the need for comprehensive health assessments in individuals with Down syndrome.
Purpose of the Study:
- To investigate the hormonal profile and gonadal function in women with Down syndrome.
- To identify potential endocrine abnormalities contributing to health issues in this population.
Main Methods:
- Ultrasound examination of internal genitalia in 13 females with trisomy 21.
- Hormonal assays including FSH, LH, estradiol (E2), prolactin (PRL), DHEA-S, testosterone (T), and 17-hydroxyprogesterone (17-OHP).
Main Results:
- Ultrasonography revealed normal uterine and ovarian morphology and size.
- Mean concentrations of FSH, dehydroepiandrosterone sulfate (DHEA-S), and estradiol (E2) were within normal ranges.
- Significantly elevated levels of luteinizing hormone (LH), testosterone (T), and 17-hydroxyprogesterone (17-OHP) were observed compared to controls.
Conclusions:
- The study provides novel insights into the gonadal function of women with Down syndrome.
- Elevated levels of certain hormones suggest potential alterations in the pituitary-gonadal and pituitary-adrenal axes.
- Further specialized studies are recommended to elucidate these axis functions.